I-80 Gold is selling $200 million of convertible bonds to help advance the miner's five gold projects, refurbish a processing plant and fund the expansion of its resource base. The Nevada-focused gold ...

Nebius Group N.V. NBIS shares slid in premarket trading on Wednesday to recover later. The company announced an upsized ...

Ormat Technologies (ORA) on Tuesday said it plans to offer $750 million in convertible senior notes through private placements, comprising $600 million of Series A notes and $150 million of Series B ...

Shares of Nebius Group declined on plans to raise $3.75 billion through a private offering of convertible senior notes as it ramps up its artificial intelligence infrastructure expansion. The stock ...

In recent days, Dave Inc. completed a US$175,000,000 Rule 144A private offering of senior unsecured zero-coupon convertible notes due April 1, 2031, following the release of its fourth-quarter and ...

Calgary, Alberta / October 15, 2025 –TheNewswire -Credissential Inc. (“Credissential” or the “Company”) (CSE: WHIP), a vertically integrated AI software development companyis pleased to announce a non ...

Convertible notes are agreements where investors lend money to a company, with the expectation that the loan will convert into equity at a later date, usually during the next significant financing ...

"We are extremely pleased with the outstanding response to the Convertible Note Offering from high quality institutional investors in the United States, which is a tremendous endorsement of Caledonia ...

VANCOUVER, BC AND BREDA, NETHERLANDS / ACCESS Newswire / November 17, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTCQX:OGOFF)(FSE:OGF0) (“Organto” or the “Company”), is pleased to announce that it has ...

CRISPR Therapeutics (NASDAQ:CRSP) has had a rough stretch lately. Shares have dropped 5% over the past week and are down 8% year-to-date, trading around $49.37 as of Tuesday morning. Piper Sandler, ...

The additional note was issued on March 16, 2026 under the company’s previously announced senior secured convertible note ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced an amendment to ...